HLB Genex, Inc. (KOSDAQ:187420)
South Korea
· Delayed Price · Currency is KRW 3,145.00
-55.00 (-1.72%)
At close: Jun 26, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Enzymes and Material Business | 25.50B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Enzymes and Material Business Growth | -8.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Drug Development | 1.51B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Other | 3.22B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 9.69% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | 18.36B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | 7.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Netherlands | 2.63B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Netherlands Growth | -42.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| England | 1.96B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| England Growth | 35.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 851.64M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | -52.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 3.22B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 9.69% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|